It’s amazing how cheaply we acquired GDC-0084 and its terrific to see study after study start with little or no cost to us.
Across two compounds we now have 5 clinical studies running with money to cover us until well after results on key studies are reported so it really looks like this next 6 months will be very exciting times for KZA.
